Outsourced Drug Development Solutions

  1. Potent, Selective Modulators Of Protein Functions 10/17/2023

    Explore chemical probes that are selective small-molecule modulators of a protein’s function.

  2. Xcellerex™ X-Platform Bioreactors: A Next-Generation Single-Use Bioreactor System 11/6/2025

    Accelerate your gene therapy manufacturing with the Xcellerex™ X-platform – a next-generation single-use bioreactor system designed for viral vector workflows.

  3. Enhance Your Workflow With A High-Speed Centrifuge System 9/6/2023

    Enhance your workflow with the Avanti JXN-26 high-speed Centrifuge System

    • 6.0 L Max Capacity
    • 26,000 RPM
    • 81,770 x g
  4. Maximizing Impact With High-Purity, And Non Animal Origin Squalene 7/21/2025

    Enabling you to design vaccines without reliance on animal sources with our fermentation-produced squalene.

  5. Inverted Microscope Solution- DMi8 S 6/27/2023

    Find the missing links

    The modular DMi8 inverted microscope is the heart of the DMi8 S platform solution. For routine to live cell research, the DMi8 S platform is a complete solution. Whether you need to precisely follow the development of a single cell in a dish, screen through multiple assays, obtain single molecule resolution, or tease out behaviors of complex processes, a DMi8 S system will enable you to see more, see faster, and find the hidden.

    • See more – Increase your viewing area up to 10,000x
    • See faster – Experiments up to 5x faster
    • See the hidden – Activate, ablate, and bleach within one experiment
  6. ImageXpress Confocal HT.ai High-Content Imaging System 6/21/2023

    A scalable, high-throughput, high-content screening solution with 7-channel high-intensity laser light source and machine learning capabilities.

  7. High Potency Handling Capabilities And Support 10/15/2025

    Highly potent APIs require stringent containment and precise manufacturing controls. Specialized facilities offer end-to-end development solutions and robust cross-contamination protections.

  8. Patient-Derived Assay-Ready Organoids 3/10/2025

    Gain human-relevant insights with patient-derived assay-ready organoids.

  9. Analytical And Testing Services 2/2/2022

    As part of Stevanato Group’s commitment to R&D, our analytical testing facilities focus on investigating physico-chemical properties of primary packaging materials and components and studying the interactions between container closure system and drugs. Stevanato Group relies on a multi-disciplinary team of highly skilled professionals, including, scientists, engineers, pharmaceutical chemists and biotechnologists. Their knowledge and experience covers a range of specialized areas including container closure systems and drug-delivery devices.

  10. Bionanoparticle Technology 4/24/2023

    Nanoform’s proprietary bionanoparticle technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. This can not only enable more patient-friendly approaches to drug delivery, but also potentially higher loads of active ingredients.